HST Global, Inc. - Quarter Report: 2019 June (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended

June 30, 2019

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number 000-15303

HST Global, Inc.

(Exact name of registrant as specified in its charter)

Nevada	73-1215433
(State or other jurisdiction of incorporation or organization)	(I. R. S. Employer Identification No.)

150 Research Drive, Hampton, VA	23666
(Address of principal executive offices)	(Zip Code)

757-766-6100

(Registrant’s telephone number, including area code)

n/a

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ ] No [x]

Page 1

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]

Accelerated filer [ ]

Non-accelerated filer [ x ]

Smaller reporting company [x]

Emerging growth Company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes [ ] No [x]

The number of shares of the registrant’s common stock outstanding as of August 19, 2019 was 51,719,854 shares.

Page 2

TABLE OF CONTENTS

PART I -	FINANCIAL INFORMATION	3
Item 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets (unaudited)	4
	Condensed Consolidated Statements of Operations (unaudited)	5
	Condensed Consolidated Statement of Cash Flow	6
	Condensed Consolidated Statement of Shareholder Deficit	7
	Notes to Condensed Consolidated Financial Statements (unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Conditions and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	14
Item 4.	Controls and Procedures	14
PART II	OTHER INFORMATION	15
Item 1.	Legal Proceedings	15
Item 2.	Unregistered Sales of Equity Securities	15
Item 3.	Default Upon Senior Securities	15
Item 4.	Mine Safety Disclosures	16
Item 5.	Other Information	16
Item 6.	Exhibits	16
Signatures		16

Page 3

HST GLOBAL, INC.

Condensed Consolidated Balance Sheets

	June 30, 2019	December 31, 2018
	(Unaudited)
ASSETS

Current Assets
Cash and cash equivalents	`$-`	`$-`
Total Current Assets	`-`	`-`

Total Assets	`$-`	`$-`

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
Bank overdraft payable	`$3,702`	`$2,957`
Accounts payable and accrued expenses	`-`	`3.228`
Accounts payable and accrued expenses - related parties	`96,728`	`505,959`
Accrued officer compensation	`70,000`	`1,110,000`
Accrued related party interest	`123,176`	`376,629`
Notes payable - related party	`671,300`	`1,372,169`
Total Current Liabilities	`964,906`	`3,370,942`

Total Liabilities	`964,906`	`3,370,942`

Stockholders' Deficit
Preferred stock; 5,000,000 shares authorized, at $0.001 par value, - 0- shares issued and outstanding, respectively	`-`	`-`
Common stock; 100,000,000 shares authorized, at $0.001 par value, 51,719,854 and 36,719,854 shares issued and outstanding, respectively	`51,720`	`36,720`
Additional paid-in capital	`4,864,800`	`2,384,824`
Accumulated deficit	`(5,881,426)`	`(5,792,486)`
Total Stockholders' Deficit	`(964,906)`	`(3,370,942)`

Total Liabilities and Stockholders' Deficit	`$-`	`$-`

The accompanying notes are an integral part of these financial statements

Page 4

HST GLOBAL, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

	For the Three Months Ended		For the Six Months Ended
	June 30,		June 30,
	2019	2018	2019	2018
REVENUES	-	-	-	-

OPERATING EXPENSES
Consulting	30,000	30,000	60,000	60,000
General and administrative	4,758	5,456	11,066	13,332

Total Operating Expenses	34,758	35,456	71,066	73,332

Loss from Operations	(34,758)	(35,456)	(71,066)	(73,332)

OTHER INCOME (EXPENSE)

Interest expense	(8,937)	(8,937)	(17,874)	(17,874)

Total Other Income (Expense)	(8,937)	(8,937)	(17,874)	(17,874)

Loss Before Income Taxes	(43,695)	(44,393)	(88,940)	(91,206)
Provision for Income Taxes	-	-	-	-
NET LOSS	(43,695)	(44,393)	(88,940)	(91,206)

Basic and Diluted Loss Per Share	(0.00)	(0.00)	(0.00)	(0.00)

Basic and Diluted Weighted Average Number of Common Shares Outstanding	37,049,524	36,719,854	36,885,600	36,719,854

The accompanying notes are an integral part of these financial statements

Page 5

HST GLOBAL, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	For the Six Months Ended
	June 30,
	2019	2018
Operating Activities

Net loss	`$(88,940)`	`$(91,206)`
Adjustments to reconcile net loss to net cash used in operating activities:
Changes in operating assets and liabilities:
Bank overdraft payable	`745`	`2,342`
Accounts payable and accrued expenses	`(2,779)`	`(1,101)`
Accrued officer compensation	`60,000`	`60,000`
Accrued related party interest	`17,874`	`17,874`

Net Cash Used in Operating Activities	`(13,100)`	`(12,091)`

Investing Activities

Net Cash Used in Investing Activities	`-`	`-`

Financing Activities

Proceeds from notes payable - related party	`13,100`	`11,800`

Net Cash Provided by Financing Activities	`13,100`	`11,800`

Net Change in Cash and Cash Equivalents	`-`	`(291)`

Cash and Cash Equivalents at Beginning of Period	`-`	`291`

Cash and Cash Equivalents at End of Period	`$-`	`$-`

Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	`$-`	`$-`
Cash paid for taxes	`$-`	`$-`

Non-Cash Financing Activities:
Common stock issued for debt	`$2,494,976`	`-`

The accompanying notes are an integral part of these financial statements

Page 6

HST Global, Inc.

Condensed Consolidated Statements of Stockholders’ Deficit
(Unaudited)

	Preferred Stock		Common Stock		Additional Paid-in	Accumulated	Total Stockholder’s
	Shares	Amount	Shares	Amount	Capital	Deficit	Deficit
Balance, December 31, 2017	`-`	`$-`	`36,719,854`	`$36,720`	`$2,384,824`	`$(5,614,151)`	`$(3,192,607)`
Net loss	`-`	`-`	`-`	`-`	`-`	`(46,814)`	`(46,814)`
Balance, March 31, 2018	`-`	`$-`	`36,719,854`	`$36,720`	`$2,384,824`	`$(5,660,965)`	`$(3,239,421)`
Net loss	`-`	`-`	`-`	`-`	`-`	`(44,393)`	`(44,393)`
Balance, June 30, 2018	`-`	`$-`	`36,719,854`	`$36,720`	`$2,384,824`	`$(5,705,357)`	`$(3,283,813)`

Balance, December 31, 2018	`-`	`$-`	`36,719,854`	`$36,720`	`$2,384,824`	`$(5,792,486)`	`$(3,370,942)`
Net loss	`-`	`-`	`-`	`-`	`-`	`(45,245)`	`(45,245)`
Balance, March 31, 2019	`-`	`$-`	`36,719,854`	`$36,720`	`$2,384,824`	`$(5,837,731)`	`$(3,416,187)`
Conversion of related Party debt			`15,000,000`	`15,000`	`$2,479,976`		`$2,494,976`
Net loss	`-`	`-`	`-`	`-`	`-`	`(43,695)`	`(43,695)`
Balance, June 30, 2019	`-`	`$-`	`51,719,854`	`51,720`	`4,864,800`	`$(5,881,426)`	`$(964,906)`

The accompanying notes are an integral part of these financial statements

Page 7

HST GLOBAL, INC.

Notes to Condensed Consolidated Financial Statements (Unaudited)

June 30, 2019

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES

HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.

HST Global, Inc. is an integrated Health and Wellness Biotechnology company that is developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases. In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.

Interim Financial Statements

These interim unaudited financial statements have been prepared on the same basis as the annual financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period.

Principles of Consolidation

The condensed consolidated financial statements include our wholly-owned subsidiary. Intercompany balances and transactions have been eliminated.

The accompanying notes are an integral part of these financial statements

Page 8

Accounting Method

The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

Basic and Diluted Income (Loss) Per Share

The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. The Company had no common stock equivalents outstanding as of June 30, 2018 and 2019.

Stock-Based Compensation

The Company adopted ASC 718, “Stock Compensation”, upon inception at August 6, 2007. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the income statement based on their fair values. As of June 30, 2019, the Company has not issued any employer stock options.

Fair Value of Financial Instruments

The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.

The accompanying notes are an integral part of these financial statements

Page 9

The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows:

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1.

Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).

Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.

Recently Issued Accounting Pronouncements

ASC 842, Leases, was added by ASU 2016-02 on February 25, 2016, effective for fiscal periods beginning after December 15, 2018 and interim periods therein. ASC 842 provides the requirements of financial accounting and reporting for lessees and lessors. The Company has adopted ASC 842 on January 1, 2019and has concluded that no adjustments were needed.

Management has considered all other recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

NOTE 3 – GOING CONCERN

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the money it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing

The accompanying notes are an integral part of these financial statements

Page 10

and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 4 – RELATED PARTY TRANSACTIONS

Consulting Agreements

The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010. The Company had agreed to continue to engage Mr. Howell as a consultant until his consulting services are no longer required. As of June 30, 2019, and December 31, 2018, the Company owed Mr. Howell $0 and $1,040,000, respectively based on the terms of the agreement on June 28, 2019. Mr. Howell agreed to exchange this payable for restricted common stock as part of the conversion of all of the money owed him and his affiliates in the amount of $2,494,976 in a series of debt exchange transactions as follows:

The Company issued 11,184,920 shares of restricted common shares to Ron Howell CEO for conversion of $1,860,407 owed to him by the Company for loans, consulting fees, reimbursements or other payables to equity in full payment of all obligations.

The Company issued 3,639,592 shares of Common stock to The Health Network, Inc., a company controlled by Ron Howell, CEO of the Company for conversion of $605,379, the total amount of money owed to The Health Network, Inc. by the Company for loans, fees, reimbursements or other payables in full payment of all obligations.

The Company issued 116,996 shares of Common stock of HST Global, Inc. shares of Common stock to LIFT, LLC., a company controlled by Ron Howell, CEO of the Company to convert $19,460 the total amount of money owed to LIFT, LLC by the Company for loans, fees, reimbursements or other payables in full payment of all obligations.

The Company issued 58,492 shares of Common stock of HST Global, Inc shares of restricted Common stock to Biolifecycle, LLC., a company controlled by Ron Howell, CEO of the Company to convert $9,729 the total amount of money owed to Biolifecycle, LLC by the Company for loans, fees, reimbursements or other payables in full payment of all obligations.

The value of the shares based on the trading price on June 26, 2019 was $150,000. The Company determined the difference between the debt calculated and the value of the shares, $2,344,976 was a capital transaction and was recorded in Additional Paid in Capital due to the related party nature of the transactions

The Company has entered into a consulting agreement with Eric Clemons, a shareholder of the Company, whereby the Company agreed to pay Mr. Clemons $10,000 per month for consulting services through December 2009. This employment agreement carried the provision that it could be extended beyond this date upon mutual agreement by both parties and that the agreement could be canceled by the Company at any time after that date. Mr. Clemons received 1,471,419 shares of common stock valued at $103,000 as a partial payment for amounts owed under this agreement in January of 2010. The Company continued to accrue amounts owed under this agreement through July of 2010. The balance owed to Mr. Clemons at

The accompanying notes are an integral part of these financial statements

Page 11

June 30, 2019 and December 31, 2018 is $70,000 and $70,000, respectively under this agreement. The Company disputes this amount and is currently assessing legal issues surrounding this obligation with the intention of relying on extinguishing this obligation based on the opinion of the Company’s council and accounting guidelines to eliminate this debt by having it determined to be uncollectable.

Executive Offices

The Company's executive offices are located at 150 Research Dr., Hampton VA. These offices are leased by The Health Network, Inc. ("THN"), of which Ron Howell is President. THN allows the Company to use the office space without a formal sublease or rental agreement. The Company previously accrued $15,000 per month for a general operating fee, which covered the use of office space, certain equipment, and various other services. However, due to the Company having limited available resources, THN has agreed to lease the Company office space at no charge. As of June 28, 2019 , the Company owed THN an amount of $365,462. Included in the agreement for THN to convert the funds owed to it by the Company, THN agreed to include the extinguishment of this payable as part of the debt conversion with HST in the transaction that THN accepted to convert this portion of the THN payable for all debt owed to THN for 3,639,592 shares of the Company’s restricted common stock and at June 30, 2019, the Company owed $0 to THN for this obligations.

NOTE 5 – COMMON STOCK

The Company issued 3,639,592 shares of Common stock to Health Net Inc. a company controlled by Ron Howell, CEO of the Company for conversion of $605,379, the total amount of money owed to Health Net, LLC by the Company for loans, fees, reimbursements or other payables. In full payment of all obligations.

NOTE 6 – SUBSEQUENT EVENTS

On August 9, 2019, HST Global, Inc., a Nevada corporation (the “Company”), entered into an Asset Purchase Agreement (the “Agreement”) with Orbital Group, Inc., a Nevada corporation (the “Seller”) to purchase the Seller’s contract rights (the “Assets”) to a revenue sharing agreement between Orbital Group, Inc. (also referred to herein as “Seller” or “OGI”) and VeraClaim, Ltd. (referred to herein as VeraClaim)Acquisition. Subject to the terms and conditions of Agreement between VeraClaim, Ltd. and

The accompanying notes are an integral part of these financial statements

Page 12

Orbital Group, Inc., Orbital Group, Inc has limited Rights to market the services and products know as and based on the RevSource Platform and its associated products and services owned by VeraClaim, Ltd. in the Territory, which includes all countries of the world to potential clients in all countries of the world.

VeraClaim, Ltd. has not sold, transferred or assigned to Orbital Group, Inc. intellectual and physical property relating to the RevSource Platform or any and associated products or services.

The Acquisition is subject to customary closing conditions and is expected to close on or around August 9, 2019. Prior to closing the Acquisition, the Company will effect a reverse stock split of its common stock sufficient to ensure that no more than 3,450,000 shares of common stock are outstanding immediately prior to closing the Acquisition, and at closing of the Acquisition, the Company will pay to the Seller 19,500,000 shares of Company common stock as the purchase price for the Assets.

The accompanying notes are an integral part of these financial statements

Page 13

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the information contained in the condensed consolidated financial statements of the Company and the notes thereto appearing elsewhere herein. As used in this report, the terms "Company", "we", "our", "us" and "HSTC" refer to HST Global, Inc.

Preliminary Note Regarding Forward-Looking Statements

This quarterly report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as "anticipate," "expect," "intend," "plan," "will," "we believe," "HSTC believes," "management believes" and similar language. The forward-looking statements are based on the current expectations of HSTC and are subject to certain risks, uncertainties and assumptions, including those set forth in the discussion under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this report. The actual results may differ materially from results anticipated in these forward-looking statements. We base the forward-looking statements on information currently available to us, and we assume no obligation to update them. Investors are also advised to refer to the information in our filings with the Securities and Exchange Commission, especially on Forms 10-K, 10-Q and 8-K, in which we discuss in more detail various important factors that could cause actual results to differ from expected or historic results. It is not possible to foresee or identify all such factors. As such, investors should not consider any list of such factors to be an exhaustive statement of all risks and uncertainties or potentially inaccurate assumptions.

Critical Accounting Policies and Estimates

Our financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States ("US GAAP"). US GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.

Results of Operations – The Three Months Ended June 30, 2019 as Compared to the Three Months Ended June 30, 2018

The Company had revenues of $0 for the quarter ended June 30, 2019 as compared to $0 for the quarter ended June 30, 2018. The costs of sales for the same period were $0 in 2019 as compared to $0 for 2018. The Company incurred expenses of $43,695 for the quarter ended June 30, 2019 as compared to $44,393 for the quarter ended June 30, 2018. This represents a $698 decrease in the loss from operation for the 2nd quarter of 2019, which is attributable to a decrease in general and administrative expenses. The expenses in the 2nd quarter 2019 were incurred to further the company’s General and Administrative/Consulting efforts and expanding the company’s strategic plan of opening wellness clinics worldwide, with the addition

The accompanying notes are an integral part of these financial statements

Page 14

of finding or creating business opportunities in medical related financial services. Until the Company obtains capital required to become active in the medical financial services segment of the medical market place businesses and obtains the revenues needed from its future operations to meet its obligations, the Company will be dependent upon sources other than operating revenues to meet its operating and capital needs. Operating revenues may never satisfy these needs.

Results of Operations – The Six Months Ended June 30, 2019 as Compared to the Six Months Ended June 30, 2018

The Company had revenues of $0 for the six months ended June 30, 2019 as compared to $0 for the six months ended June 30, 2018. The costs of sales for the same period were $0 in 2019 as compared to $0 for 2018. The Company incurred expenses of $88,940 for the six months ended June 30, 2019 as compared to $91,206 for the six months ended June 30, 2018. This represents a $2,226 decrease, which is attributable to a decrease in general and administrative expenses. The expenses in the 1st and 2nd quarters of 2019 were incurred to further the company’s General and Administrative/Consulting efforts and expanding the company’s strategic plan of opening wellness clinics worldwide, with the addition of finding or creating business opportunities in medical related financial services. Until the Company obtains capital required to become active in the medical financial services segment of the medical market place businesses and obtains the revenues needed from its future operations to meet its obligations, the Company will be dependent upon sources other than operating revenues to meet its operating and capital needs. Operating revenues may never satisfy these needs.

Liquidity and Capital Resources

Our cash balance as of June 30, 2019 was $0.

The Company does not currently have sufficient capital in its accounts, nor sufficient firm commitments for capital to assure its ability to meet its current obligations or to continue its planned operations. The Company is continuing to pursue working capital and additional revenue through the seeking of the capital it needs to carry on its planned operations. There is no assurance that any of the planned activities will be successful.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

None.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Interim Chief Financial Officer (the "Certifying Officer") maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management timely. Under the supervision and with the participation of management, the Certifying Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)] under the Exchange Act) within 45 days prior to the filing date of this report. Based upon that evaluation, the Certifying Officer concluded that our disclosure controls and procedures are not effective in timely alerting them to material information relative to our company that should be required to

The accompanying notes are an integral part of these financial statements

Page 15

be disclosed in our periodic filings with the SEC. As the Company adds working capital and expands in operations, the Company intends to strengthen its Controls and procedures with additional staff and outside services.

Changes in Internal Controls

During the Quarter ended June 30, 2019, there were no changes made to our internal controls over financial reporting that are reasonably likely to affect the reliability of those controls, or the accuracy of our financial reporting.

The accompanying notes are an integral part of these financial statements

Page 16

PART II: OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The securities described above were issued to investors in reliance upon the exemption from registration requirements of the Securities Act, as set forth in Section 4(2) under the Securities Act and Regulation D promulgated thereunder relating to transactions by an issuer not involving any public offering. No commissions were paid and no agreements to register shares were offered in the private placements.

All Purchasers of shares described above represented to us in connection with their purchase that they were accredited investors and were acquiring the shares for their own account for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof. The purchasers received written disclosures that the securities had not been registered under the Securities Act and that any resale must be made pursuant to a registration statement or an available exemption from such registration.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

The accompanying notes are an integral part of these financial statements

Page 17

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following exhibits are filed as part of this quarterly report on Form 10-Q:

Exhibit No.		Description
31.1		Certification by the Chief Executive Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).
31.2		Certification by the Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).
32.1		Certification by the Chief Executive Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
32.2		Certification by the Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
101		Interactive Data Files

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: August 19, 2019	HST GLOBAL, INC.
	(the registrant)

	By:	\s\ Ron Howell
	Ron Howell
	Chief Executive Officer
	Interim Chief Financial Officer

The accompanying notes are an integral part of these financial statements

Page 18